Anthem Biosciences Limited — Results, 02-07-2026: Reply to Clarification- Financial results
02-07-2026 | 06:34 pm
02-07-2026 | 06:34 pm
Anthem Biosciences clarified FY26 results. The reported PAT of INR 591.79 Cr was consistent across filings. Consolidated EPS omission in XBRL was a clerical error, not impacting other financials. A revised XBRL filing is being submitted.
No comments yet. Be the first to comment!
